D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
CNCE holding history
Concert Pharmaceuticals, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CNCE overviewAll 13F holders of CNCEFull Q2 2026 holdings
- Shares (Q1 2023)
- 0
- Sold out in Q1 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2023 | 0 | $0 | 0.0% | −113,848−100.0% | Sold out | Holders |
| Q4 2022 | 113,848 | $664.9K | <0.1% | +113,848 | New | Holders |
| Q3 2022 | 0 | $0 | 0.0% | −25,901−100.0% | Sold out | Holders |
| Q2 2022 | 25,901 | $109.0K | <0.1% | −6,646−20.4% | Reduced | Holders |
| Q1 2022 | 32,547 | $110.0K | <0.1% | −12,772−28.2% | Reduced | Holders |
| Q4 2021 | 45,319 | $143.0K | <0.1% | +18,296+67.7% | Added | Holders |
| Q3 2021 | 27,023 | $88.0K | <0.1% | −4,704−14.8% | Reduced | Holders |
| Q2 2021 | 31,727 | $134.0K | <0.1% | −37,102−53.9% | Reduced | Holders |
| Q1 2021 | 68,829 | $344.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.